Oxytocin intranasal (Teijin Pharma)

N/A

Report date: 2024/12/04 15:51:17

Base Information

Drug NameOxytocin intranasal (Teijin Pharma)
Drug Alias NameTTA-121
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOxytocin receptor agonists
TargetsOxytocin receptor
Therapy Area/IndicationsPainFibromyalgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTeijin Pharma
China Registration ClassN/A

Develop Information

Active CompaniesTeijin Pharma
Inactive CompaniesN/A
Active IndicationsPainFibromyalgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A